Dollars, Not New Authorities Needed To Advance Precision Medicine, FDA Chiefs Say
This article was originally published in The Gray Sheet
Executive Summary
FDA and NIH officials appreciate a helping hand from Congress when it comes to funding for advancing precision medicine and advanced diagnostics, but they may be wary of taking too much direction from lawmakers on how to run the programs.